Clonal spread and patient risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy

被引:47
|
作者
Zarrilli, R. [1 ,2 ]
Di Popolo, A. [1 ]
Bagattini, M. [1 ]
Giannouli, M. [1 ]
Martino, D. [1 ]
Barchitta, M. [3 ]
Quattrocchi, A. [3 ]
Iula, V. D. [4 ]
de Luca, C. [4 ]
Scarcella, A. [5 ]
Triassi, M. [1 ]
Agodi, A. [3 ]
机构
[1] Univ Naples Federico II, Dept Prevent Med Sci, Hyg Sect, I-80131 Naples, Italy
[2] CEINGE Adv Biotechnol, Naples, Italy
[3] Univ Catania, Dept GF Ingrassia, Catania, Italy
[4] Univ Naples Federico II, Dept Mol & Cellular Biol & Pathol L Califano, I-80131 Naples, Italy
[5] Univ Naples Federico II, Dept Paediat, I-80131 Naples, Italy
关键词
Acinetobacter baumannii; Extensively drug-resistant; Neonatal intensive care unit; Cross-transmission; Genotyping; Infection control; Risk factor analysis; MOLECULAR EPIDEMIOLOGY; PSEUDOMONAS-AERUGINOSA; INFECTION; OUTBREAK; COLONIZATION; EMERGENCE; SHOWS; ICU;
D O I
10.1016/j.jhin.2012.08.018
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Aim: To report an outbreak of extensively drug-resistant (XDR) Acinetobacter baumannii in the neonatal intensive care unit (NICU) of an Italian university hospital. Patient risk profiles for acquisition of A. baumannii and measures used to control the outbreak are described. Methods: Antibiotic susceptibility of strains was evaluated by microdilution. Genotyping was performed by pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing. Carbapenemase genes were analysed by polymerase chain reaction and DNA sequencing. A case-control study was designed to identify risk factors for acquisition of A. baumannii. Findings: A. baumannii was isolated from 22 neonates, six of whom were infected. One major PFGE type was identified, assigned to sequence type (ST) 2, corresponding to International Clone II; this was indistinguishable from isolates from the adult ICU in the same hospital. A. baumannii isolates were resistant to aminoglycosides, quinolones and classes of beta-lactam antibiotics, but were susceptible to tigecycline and colistin. Carbapenem resistance was associated with the presence of transposon Tn2006 carrying the bla(OxA)-23 gene. Length of NICU stay, length of exposure to A. baumannii, gestational age, use of invasive devices and length of exposure to invasive devices were significantly associated with acquisition of A. baumannii on univariate analysis, while length of exposure to central venous catheters and assisted ventilation were the only independent risk factors after multi-variate analysis. Conclusions: This XDR A. baumannii outbreak in an NICU was probably caused by intra-hospital transfer of bacteria via a colonized neonate whose mother was admitted to the adult ICU. Strengthened infection control measures were necessary to control the outbreak. (C) 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:260 / 265
页数:6
相关论文
共 50 条
  • [31] Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia
    Zeng, Jiawei
    Zhang, Lidan
    Gao, Min
    Wu, Jingjing
    Wu, Haiyan
    Chen, Jie
    Chen, Xiao
    Tang, Wen
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 61 : 23 - 26
  • [32] Risk Factors For Acquisition Of Multidrug Resistant Acinectobacter Baumannii (mrab) In An Intensive Care Unit
    Hong, J.
    Shin, J.
    Chung, K.
    Kang, Y.
    Kim, S.
    Chang, J.
    Kim, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [33] Acinetobacter baumannii infection in the neonatal intensive care unit
    Jarousha, A. M. K. A. L.
    El Qouqa, I. A.
    Jadba, A. H. N. E. L.
    Al Afifi, A. S.
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2008, 37 (03) : 107 - 112
  • [34] Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates
    Deolankar, Manas S.
    Carr, Rachel A.
    Fliorent, Rebecca
    Roh, Sean
    Fraimow, Henry
    Carabetta, Valerie J.
    ANTIBIOTICS-BASEL, 2022, 11 (10):
  • [35] Molecular characterisation of extensively drug-resistant Acinetobacter baumannii: First report of a new sequence type in Italy
    Ambrosi, Cecilia
    Aleandri, Marta
    Giordano, Alessandra
    Scribano, Daniela
    Marazzato, Massimiliano
    Zagaglia, Carlo
    Conte, Maria Pia
    Palamara, Anna Teresa
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2016, 7 : 154 - 156
  • [36] Carbapenem-resistant Acinetobacter baumannii infections: Antimicrobial resistance patterns and risk factors for acquisition in a Kenyan intensive care unit
    Kipsang, Fred
    Munyiva, Jeniffer
    Menza, Nelson
    Musyoki, Abednego
    IJID REGIONS, 2023, 9 : 111 - 116
  • [37] Colonization pressure and risk factors for acquisition of imipenem-resistant Acinetobacter baumannii in a medical surgical intensive care unit in Brazil
    Castelo Branco Fortaleza, Carlos Magno
    de Freitas, Fernanda Moreira
    Lauterbach, Gerhard da Paz
    AMERICAN JOURNAL OF INFECTION CONTROL, 2013, 41 (03) : 263 - 265
  • [38] Risk factors for acquisition of methicillin-resistant Staphylococcus aureus and clonal spread of the isolates in a medical intensive care unit
    Alp, Emine
    Yerer, Mehmet
    Esel, Duygu
    Metan, Goekhan
    Doganay, Mehmet
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2009, 39 (06) : 941 - 951
  • [39] Clinical features, risk factors, and outcome of carbapenem-resistant Acinetobacter baumannii bacteremia in a Thai neonatal intensive care unit
    Nakwan, Narongsak
    Wannaro, Jeerawan
    Nakwan, Narongwit
    Patungkalo, Wichian
    Chokephaibulkit, Kulkanya
    ASIAN BIOMEDICINE, 2012, 6 (03) : 473 - 479
  • [40] Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections
    Viehman, J. Alexander
    Hong Nguyen, M.
    Doi, Yohei
    DRUGS, 2014, 74 (12) : 1315 - 1333